HekeTiss is pleased to announce that the RESCUE-PATCH Phase I/IIa clinical trial has reached 50% of its planned patient recruitment, marking an important milestone in the clinical development of TrophiPatch™.

The first-in-human study is evaluating the safety and preliminary efficacy of TrophiPatch™ in patients with chronic, non-healing wounds. The trial is sponsored by the Division of Dermatology at the University Hospitals of Geneva (HUG) and conducted in collaboration with HekeTiss.

Patient recruitment and clinical follow-up are ongoing as the study progresses toward completion.

This milestone represents another important step in the clinical evaluation of TrophiPatch™ and the advancement of HekeTiss' regenerative approach for chronic wound care.

Image: Vecteezy.com